日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Aspergillus oryzae Protein cft1 (cft1), partial CSB-YP649585DPA
CSB-EP649585DPA
CSB-BP649585DPA
CSB-MP649585DPA
CSB-EP649585DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Histone-lysine N-methyltransferase set9 (set9), partial CSB-YP649586DPA
CSB-EP649586DPA
CSB-BP649586DPA
CSB-MP649586DPA
CSB-EP649586DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable pectate lyase B (plyB) CSB-YP649587DPA
CSB-EP649587DPA
CSB-BP649587DPA
CSB-MP649587DPA
CSB-EP649587DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Polynucleotide 5'-hydroxyl-kinase grc3 (grc3), partial CSB-YP649588DPA
CSB-EP649588DPA
CSB-BP649588DPA
CSB-MP649588DPA
CSB-EP649588DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable cutinase 3 (AO090011000113) CSB-YP649589DPA
CSB-EP649589DPA
CSB-BP649589DPA
CSB-MP649589DPA
CSB-EP649589DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable mannan endo-1,4-beta-mannosidase F (manF) CSB-YP649590DPA
CSB-EP649590DPA
CSB-BP649590DPA
CSB-MP649590DPA
CSB-EP649590DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Translation factor guf1, mitochondrial (guf1), partial CSB-YP649591DPA
CSB-EP649591DPA
CSB-BP649591DPA
CSB-MP649591DPA
CSB-EP649591DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Molybdopterin synthase catalytic subunit (mocs2) CSB-YP649592DPA
CSB-EP649592DPA
CSB-BP649592DPA
CSB-MP649592DPA
CSB-EP649592DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae ATP-dependent RNA helicase chl1 (chl1), partial CSB-YP649593DPA
CSB-EP649593DPA
CSB-BP649593DPA
CSB-MP649593DPA
CSB-EP649593DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Peptidyl-prolyl cis-trans isomerase-like 2 (cyp8), partial CSB-YP649594DPA
CSB-EP649594DPA
CSB-BP649594DPA
CSB-MP649594DPA
CSB-EP649594DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae DNA ligase 4 (lig4), partial CSB-YP649595DPA
CSB-EP649595DPA
CSB-BP649595DPA
CSB-MP649595DPA
CSB-EP649595DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae ATP-dependent RNA helicase sub2 (sub2) CSB-YP649596DPA
CSB-EP649596DPA
CSB-BP649596DPA
CSB-MP649596DPA
CSB-EP649596DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable alpha-L-arabinofuranosidase axhA (axhA) CSB-YP649597DPA
CSB-EP649597DPA
CSB-BP649597DPA
CSB-MP649597DPA
CSB-EP649597DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Cell division cycle protein 123 (cdc123) CSB-YP649598DPA
CSB-EP649598DPA
CSB-BP649598DPA
CSB-MP649598DPA
CSB-EP649598DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Homoaconitase, mitochondrial (lys4), partial CSB-YP649599DPA
CSB-EP649599DPA
CSB-BP649599DPA
CSB-MP649599DPA
CSB-EP649599DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Phosphatidylinositol transfer protein sfh5 (sfh5) CSB-YP649600DPA
CSB-EP649600DPA
CSB-BP649600DPA
CSB-MP649600DPA
CSB-EP649600DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Sorting nexin mvp1 (mvp1), partial CSB-YP649601DPA
CSB-EP649601DPA
CSB-BP649601DPA
CSB-MP649601DPA
CSB-EP649601DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Histone transcription regulator 3 homolog (hir3), partial CSB-YP649602DPA
CSB-EP649602DPA
CSB-BP649602DPA
CSB-MP649602DPA
CSB-EP649602DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Metacaspase-1B (casB) CSB-YP649603DPA
CSB-EP649603DPA
CSB-BP649603DPA
CSB-MP649603DPA
CSB-EP649603DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable beta-galactosidase A (lacA), partial CSB-YP649604DPA
CSB-EP649604DPA
CSB-BP649604DPA
CSB-MP649604DPA
CSB-EP649604DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×